Galmed Pharmaceuticals (NASDAQ:GLMD) shares are soaring nearly 20% in after-hours trading Wednesday, as the drug maker gets a vote of confidence from Cantor …
Analyst initiates a bullish perspective on Dynavax, ascribing a probability of 95% approval for its lead asset.
Analyst Cautiously Celebrating Biotech Player’s Stellar Q2 Performance from the Sidelines
GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) shares were falling 2% yesterday after the biotech company handed over its third-fiscal quarter print for the year, …
Cantor analyst Elemer Piros weighs in with a few insight on Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE), after the drug maker reported second-quarter results and reiterated its …
Ocular Therapeutix Inc (NASDAQ:OCUL) shares may have been falling almost 9% at the close on the heels of a class action lawsuit filed …
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) shares rose 7% to $7.49 in Friday’s trading session, after the drug maker presented additional 48-week results from its global Phase …
Cantor analyst Elemer Piros initiates coverage on shares of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH), with an Overweight rating and $14 price target, sending shares rising 4.5% in …
A recent article by Reuters indicates that GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) has made the strategic decision to hire an investment bank as …
Arrowhead on the cutting edge of providing curative hepatitis B, says Cantor analyst
